Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era.
Pabo WLRT, Njume D, Ndip RN, Takou D, Santoro MM, Chenwi C, Beloumou G, Semengue ENJ, Nka AD, Ka'e AC, Teto G, Dambaya B, Djupsa S, Nyasa RB, Anguechia DHG, Kamta C, Bala L, Lambo V, Sosso SM, Colizzi V, Perno CF, Fokam J, Ndjolo A. Pabo WLRT, et al. Among authors: takou d. J Public Health Afr. 2023 Oct 1;14(10):2612. doi: 10.4081/jphia.2023.2612. eCollection 2023 Oct 31. J Public Health Afr. 2023. PMID: 38020274 Free PMC article.
Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines.
Fokam J, Takou D, Santoro MM, Akonie HZ, Kouanfack C, Ceccherini-Silberstein F, Colizzi V, Perno CF, Ndjolo A. Fokam J, et al. Among authors: takou d. AIDS Res Hum Retroviruses. 2016 Apr;32(4):329-33. doi: 10.1089/AID.2015.0065. Epub 2016 Jan 20. AIDS Res Hum Retroviruses. 2016. PMID: 26602836
HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional Design.
Nanfack AJ, Takou D, Fokam J, Salpini R, Santoro MM, Cappelli G, Baane M, Tetang SM, Eberle J, Gürtler L, Ceccherini-Silberstein F, Torimiro JN, Colizzi V, Perno CF, Ndjolo A. Nanfack AJ, et al. Among authors: takou d. Curr HIV Res. 2016 Dec 29. Online ahead of print. Curr HIV Res. 2016. PMID: 28034359
Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains.
Fabeni L, Berno G, Fokam J, Bertoli A, Alteri C, Gori C, Forbici F, Takou D, Vergori A, Zaccarelli M, Maffongelli G, Borghi V, Latini A, Pennica A, Mastroianni CM, Montella F, Mussini C, Andreoni M, Antinori A, Perno CF, Santoro MM; Resistance Study Group. Fabeni L, et al. Among authors: takou d. J Clin Microbiol. 2017 Sep;55(9):2827-2837. doi: 10.1128/JCM.00656-17. Epub 2017 Jul 12. J Clin Microbiol. 2017. PMID: 28701420 Free PMC article.
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children.
Fokam J, Bellocchi MC, Armenia D, Nanfack AJ, Carioti L, Continenza F, Takou D, Temgoua ES, Tangimpundu C, Torimiro JN, Koki PN, Fokunang CN, Cappelli G, Ndjolo A, Colizzi V, Ceccherini-Silberstein F, Perno CF, Santoro MM. Fokam J, et al. Among authors: takou d. Medicine (Baltimore). 2018 Mar;97(13):e0176. doi: 10.1097/MD.0000000000010176. Medicine (Baltimore). 2018. PMID: 29595649 Free PMC article.
Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy.
Torimiro JN, Nanfack A, Takang W, Keou CK, Joyce AN, Njefi K, Agyingi K, Domkam I, Takou D, Moudourou S, Sosso S, Mbu RE. Torimiro JN, et al. Among authors: takou d. BMC Pregnancy Childbirth. 2018 Dec 22;18(1):504. doi: 10.1186/s12884-018-2120-7. BMC Pregnancy Childbirth. 2018. PMID: 30577760 Free PMC article.
67 results